Pacific Biosciences Of California | PACB - Cash And Equivalent


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Pacific Biosciences Of California

Pacific Biosciences Of California reported $874.89M in Cash and Equivalent for its fiscal quarter ending in March of 2023.


Cash And Equivalent Change
Accelerate Diagnostics AXDX:US USD 29.41M 5.5M
Agilent A:US USD 1.18B 75M
Bruker BRKR:US USD 597.9M 47.6M
Danaher DHR:US USD 7.38B 1.38B
General Electric GE:US USD 12B 5.26B
Illumina ILMN:US USD 1.49B 517M
Myriad Genetics MYGN:US USD 1.7M 1.6M
NanoString Technologies NSTG:US USD 121.41M 9.16M
Pacific Biosciences Of California PACB:US USD 874.89M 549.8M
PerkinElmer PKI:US USD 2.27B 1.81B
Quidel QDEL:US USD 353.9M 61M
Roche Holding ROG:VX 4.99B 676M
Standard Biotools Inc FLDM:US USD 113.66M 32.35M
Thermo Fisher Scientific TMO:US USD 3.48B 5.04B
Waters WAT:US USD 486.07M 5.54M